XenoPort (XNPT) Skyrockets On Strategic Shift; Is It Time to Look at FutureFuel (FF)?
Shares of XenoPort, Inc. (Nasdaq:XNPT) soared more than 30% in early trade Friday as the company said that it will focus on its HORIZANT, a restless legs syndrome treatment for which net sales increased 413% to $8.2 million since the second quarter of 2013. XenoPort also reported a workforce reduction, a move that represents potential $6.7 million in annual future cash savings for the company.
XNPT stock is currently trading around $4.29 and 8,306,369 of its shares exchanged hands so far, a large increase on activity versus its average volume (3m) of 979,098
XenoPort, a biopharmaceutical company, has 63.08M Shares Outstanding and XNPT stock 52-week range is between $3.35 and $9.60 per share
Equity research analysts at ROTH Capital upgraded shares of FutureFuel Corp. (NYSE:FF) from a Neutral to a Buy rating and boosted their price target on the company’s stock from $12.00 to $13.00
Shares of FutureFuel are exchanging hands at or around the $10.85 area, up $0.84 (or +8.39%)
FutureFuel, a manufacturer of custom and performance chemicals and biofuels, has 43.72M Shares Outstanding and FF stock 52-week range is $9.11 – $13.78 per share
Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://galaxystocks.com/disclaimer/